CRP and systemic sclerosis: As outlined previously (10), CRP+ SSc patients had a higher frequency of being SCL70-antibody positive (p = 0.041), whereas the CRP− SSc patients showed significantly more often positive anti-nucleosome antibodies (p = 0.013).